Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 28% ± 11% | |
kidney | 8 studies | 18% ± 3% | |
peripheral blood | 6 studies | 20% ± 5% | |
brain | 6 studies | 29% ± 11% | |
intestine | 5 studies | 23% ± 11% | |
liver | 4 studies | 34% ± 21% | |
pancreas | 3 studies | 28% ± 3% | |
eye | 3 studies | 29% ± 10% | |
thymus | 3 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 832.17 | 258 / 258 | 100% | 14.46 | 230 / 230 |
bladder | 100% | 808.95 | 21 / 21 | 100% | 15.34 | 504 / 504 |
brain | 100% | 877.93 | 2642 / 2642 | 100% | 13.76 | 705 / 705 |
esophagus | 100% | 807.90 | 1445 / 1445 | 100% | 11.90 | 183 / 183 |
kidney | 100% | 1024.17 | 89 / 89 | 100% | 11.91 | 901 / 901 |
ovary | 100% | 895.00 | 180 / 180 | 100% | 14.19 | 430 / 430 |
prostate | 100% | 954.36 | 245 / 245 | 100% | 16.30 | 502 / 502 |
thymus | 100% | 1043.09 | 653 / 653 | 100% | 21.90 | 605 / 605 |
uterus | 100% | 945.44 | 170 / 170 | 100% | 18.71 | 458 / 459 |
liver | 100% | 784.50 | 226 / 226 | 100% | 14.27 | 405 / 406 |
stomach | 100% | 722.98 | 359 / 359 | 100% | 13.43 | 285 / 286 |
intestine | 100% | 867.68 | 966 / 966 | 100% | 13.09 | 525 / 527 |
lung | 100% | 659.76 | 576 / 578 | 100% | 12.09 | 1154 / 1155 |
breast | 100% | 839.02 | 459 / 459 | 99% | 16.06 | 1112 / 1118 |
skin | 100% | 724.55 | 1808 / 1809 | 99% | 11.26 | 468 / 472 |
pancreas | 99% | 441.18 | 326 / 328 | 99% | 11.59 | 177 / 178 |
adipose | 100% | 747.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.58 | 29 / 29 |
spleen | 100% | 799.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.77 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.71 | 1 / 1 |
blood vessel | 100% | 793.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 670.53 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 697.71 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.83 | 79 / 80 |
peripheral blood | 50% | 241.87 | 460 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006364 | Biological process | rRNA processing |
GO_0005730 | Cellular component | nucleolus |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | PIN4 |
Protein name | Peptidylprolyl cis/trans isomerase, NIMA-interacting 4 Parvulin (EC 5.2.1.8) Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4) peptidylprolyl isomerase (EC 5.2.1.8) |
Synonyms | PAR14 |
Description | FUNCTION: Isoform 1 is involved as a ribosomal RNA processing factor in ribosome biogenesis. Binds to tightly bent AT-rich stretches of double-stranded DNA. .; FUNCTION: Isoform 2 binds to double-stranded DNA. . |
Accessions | ENST00000664196.1 [Q9Y237-2] D6RFY5 ENST00000652108.2 ENST00000446576.2 H0Y8P6 ENST00000218432.10 ENST00000373662.4 ENST00000496835.7 ENST00000373669.8 [Q9Y237-1] Q9Y237 ENST00000439980.7 H0Y610 ENST00000423432.6 [Q9Y237-3] J3KMW3 A8E0G8 H0Y4T6 A0A494C021 |